Raymond James Financial
ANVS icon

Raymond James Financial’s Annovis Bio ANVS Stock Holding History

Raymond James Financial’s Portfolio ANVS Stock Details ANVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-544
Closed -$1.18K – 5039
2025
Q2 		$1.18K Buy
+544
New +$1.07K ﹤0.01% 6533

Other funds holding ANVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GWM
Greenwich Wealth Management Greenwich, Connecticut $2.45B AUM 39.53% 1-Year Est. Return
WFAG
Wescott Financial Advisory Group Philadelphia, Pennsylvania $1.14B AUM 16.59% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Raymond James Financial's ANVS Position: Q3 2025 in Review

Raymond James Financial sold out of Annovis Bio (ANVS) in Q3 2025, closing a stake of 544 shares — an estimated $1.18K sold.

Raymond James Financial first reported a position in ANVS in Q2 2025 and held it in 1 quarter. The position peaked at $1.18K in Q2 2025. 42 funds tracked by Wall St. Rank hold ANVS as of Q3 2025.

  • Raymond James Financial reported no remaining Annovis Bio position as of Q3 2025 after selling out during the quarter.
  • Raymond James Financial sold 544 Annovis Bio shares in Q3 2025, an estimated $1.18K.
  • Raymond James Financial first reported a position in Annovis Bio in Q2 2025 and held it in 1 quarter.
  • Raymond James Financial's Annovis Bio position peaked at $1.18K in Q2 2025.
  • 42 funds tracked by Wall St. Rank held Annovis Bio as of Q3 2025.

Based on Raymond James Financial's 13F filing for Q3 2025, filed 14 Nov 2025.